Bruush Oral Care Inc.
BRSH · NASDAQ
10/31/2022 | 10/31/2021 | 1/31/2021 | 1/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | -0.08 | -0.00 | 0.00 |
| FCF Yield | -240.64% | -0.01% | -25.69% | -9.24% |
| EV / EBITDA | -0.49 | -1.54 | -1.81 | -11.78 |
| Quality | ||||
| ROIC | 271.63% | 139.91% | -4,608.47% | -627.47% |
| Gross Margin | 68.76% | 50.23% | 67.69% | 67.89% |
| Cash Conversion Ratio | 1.44 | 0.16 | 0.46 | 1.06 |
| Growth | ||||
| Revenue 3-Year CAGR | 42.95% | 132.91% | 965,804.72% | 591,832.76% |
| Free Cash Flow Growth | -1,394,206.66% | 99.98% | -177.86% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.01 | -0.00 | 0.08 | -0.19 |
| Interest Coverage | -2.73 | -68.28 | -459.37 | -88.39 |
| Efficiency | ||||
| Inventory Turnover | 3.41 | 1.57 | 0.25 | 0.11 |
| Cash Conversion Cycle | -272.22 | -405.91 | 1,210.42 | 1,890.30 |